|
Volumn 14, Issue 10, 1996, Pages 1216-1217
|
Can Reopro Repolish Tarnished Monoclonal Therapeutics?
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ABCIXIMAB;
ANTITHROMBOCYTIC AGENT;
IMMUNOGLOBULIN F(AB) FRAGMENT;
MONOCLONAL ANTIBODY;
ANGIOPLASTY;
ARTICLE;
BIOTECHNOLOGY;
CLINICAL TRIAL;
HUMAN;
IMMUNOTHERAPY;
NEOPLASM;
POSTOPERATIVE COMPLICATION;
ANGIOPLASTY;
ANTIBODIES, MONOCLONAL;
BIOTECHNOLOGY;
CLINICAL TRIALS;
HUMANS;
IMMUNOGLOBULIN FAB FRAGMENTS;
IMMUNOTHERAPY;
NEOPLASMS;
PLATELET AGGREGATION INHIBITORS;
POSTOPERATIVE COMPLICATIONS;
|
EID: 0030251893
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt1096-1216b Document Type: Note |
Times cited : (3)
|
References (0)
|